CM Management’s Amneal Pharmaceuticals AMRX Stock Holding History

CM Management’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-275,000	Closed	-$853K	–	67
2023 Q2	$853K	Buy	275,000 +125,000	+83%	+$266K	0.83%	37
2023 Q1	$209K	Hold	150,000	–	–	0.25%	59
2022 Q4	$299K	Hold	150,000	–	–	0.36%	59
2022 Q3	$303K	Buy	150,000 +50,000	+50%	+$140K	0.34%	65
2022 Q2	$318K	Buy	+100,000	New	+$362K	0.34%	64
2021 Q1	–	Sell	-125,000	Closed	-$571K	–	82
2020 Q4	$571K	Buy	+125,000	New	+$554K	0.53%	58

Other funds holding AMRX

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CM Management's AMRX Position: Q3 2023 in Review

CM Management sold out of Amneal Pharmaceuticals (AMRX) in Q3 2023, closing a stake of 275,000 shares — an estimated $853K sold.

CM Management first reported a position in AMRX in Q4 2020 and held it in 6 quarters. The position peaked at $853K in Q2 2023. 144 funds tracked by Wall St. Rank hold AMRX as of Q3 2023.

CM Management reported no remaining Amneal Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
CM Management sold 275,000 Amneal Pharmaceuticals shares in Q3 2023, an estimated $853K.
CM Management first reported a position in Amneal Pharmaceuticals in Q4 2020 and held it in 6 quarters.
CM Management's Amneal Pharmaceuticals position peaked at $853K in Q2 2023.
144 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2023.

Based on CM Management's 13F filing for Q3 2023, filed 7 Nov 2023.